Cryptococcal Meningitis: The Neglected Killer of People with HIV in Africa

• Cryptococcal meningitis causes approximately 135,000 deaths annually in Sub-Saharan Africa, primarily affecting people with HIV.
• The disease is characterized by fungal infections that spread to the central nervous system, often leading to severe headaches, neck stiffness, seizures, and permanent disability or death if untreated.
• Current treatment regimens are challenging to administer due to the high frequency of oral medication doses and common side effects like nausea.
• Improving diagnostic accessibility and raising community awareness are critical to reducing mortality rates through earlier intervention.

Clinical Challenges and Treatment

• Symptoms often begin with persistent headaches, fever, and neck pain, eventually progressing to loss of consciousness.
• Lumbar punctures are used to relieve intracranial pressure, though they do not address the underlying infection or reverse damage already caused, such as vision loss.
• Historical WHO protocols required multiple daily oral doses, complicating adherence for weak or nauseous patients.
• Nasogastric tube administration, often necessary for unconscious patients, poses concerns regarding accurate drug bioavailability.

Research and Future Outlook

• The 5FC HIV-Crypto trial, led by the Drugs for Neglected Diseases initiative (DNDi), is currently testing a simplified two-dose daily regimen.
• This study utilizes a sustained-release pellet formulation from Viatris to improve patient compliance.
• Results from the Phase II trial are anticipated by 2027.